Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001999144 | SCV002284885 | uncertain significance | not provided | 2022-09-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1495131). This variant has not been reported in the literature in individuals affected with PDE6A-related conditions. This variant is present in population databases (rs578228152, gnomAD 0.08%). This sequence change replaces serine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 643 of the PDE6A protein (p.Ser643Ile). |
Ambry Genetics | RCV004045462 | SCV005003361 | uncertain significance | Inborn genetic diseases | 2023-09-22 | criteria provided, single submitter | clinical testing | The c.1928G>T (p.S643I) alteration is located in exon 16 (coding exon 16) of the PDE6A gene. This alteration results from a G to T substitution at nucleotide position 1928, causing the serine (S) at amino acid position 643 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |